TRADE NEWS:
BREAKING: The Trump administration has launched a Section 301 investigation into Germany over drug pricing, arguing Berlin’s policies force Americans to subsidize pharmaceutical innovation for the rest of the world.
— Eyal Yakoby (@EYakoby) June 19, 2026